SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001654954-19-010402
Filing Date
2019-09-05
Accepted
2019-09-05 16:17:19
Documents
6
Effectiveness Date
2019-09-05

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR tgtx_s3asr.htm S-3ASR 256988
2 EXHIBIT 4.1 tgtx_ex41.htm EX-4 756654
3 EXHIBIT 5.1 tgtx_ex51.htm EX-5 40351
4 EXHIBIT 23.1 tgtx_ex231.htm EX-23 4360
5 GRAPHIC tgtx_s3000.jpg GRAPHIC 3698
6 GRAPHIC alstonlogo.jpg GRAPHIC 12944
  Complete submission text file 0001654954-19-010402.txt   1077460
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-233636 | Film No.: 191077388
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences